港股异动|友邦连续八个交易日下跌易受负面消息影响里昂下调评级
格隆汇8月2日丨友邦(1299.HK)现跌约2%,已经是连续第八个交易日下跌,报78.25港元,成交21.32亿港元,总市值9459亿港元。里昂发表研究报告指友邦(1299.HK)的高增长预期已经过去,预期上半年新业务价值增长放缓至16%,下半年更进一步缓和至仅增12%,原因包括近期香港社会运动或影响内地人购买保险的数字,虽然目前仍难以量化,但在股价今年来经历了强劲升势之后,即使是最轻微的负面消息可能会造成损害。同时短期的风险回报比例不吸引,评级由“跑赢大市”降至“跑输大市”,建议等下调后的更佳介入机会,目标价84港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.